Results

Total Results: 1,391 records

Showing results for "risks".

261. Archived: Evidence Summary: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/falls-prevention-in-older-adults-interventions-2018
     April 17, 2018 - Exercise trials were associated with statistically significant reductions in people experiencing a fall (relative … effects meta-analysis using the method of DerSimonian and Laird 11 was used to calculate the pooled relative … risks (RRs) when there was a sufficient number of contributing studies reporting an outcome for a given … IRR, incidence rate ratio; NA, not applicable; NR, not reported; RCT, randomized clinical trial; RR, relative … risk.

262. Screening for Osteoporosis: An Update for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RPB3rmcS9CK_eXPdzXSxZg
     July 01, 2010 - much higher fracture rates than younger persons with the same bone density because of increasing risks … However, in this study, DEXA of the femoral neck was associated with a higher relative risk for hip … Bisphosphonates reduced vertebral fractures compared with placebo (relative risk [RR], 0.66 [CI, 0.50 … Ten-year risks for major osteoporotic and hip fractures for U.S. white women estimated from the online … Highlighted risks equal or exceed the reference case (woman aged 65 years with no risk factors: 9.3%

263. Archived: Final Evidence Summary: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary9/breast-cancer-screening-2009
     November 15, 2009 - Pooled relative risk for breast cancer mortality from mammography screening trials compared with control … Pooled relative risk for breast cancer mortality from mammography screening trials compared with control … Figure shows a table with a bar graph in the center showing the pooled relative risk for breast cancer … Study/Author, Year (Reference) Relative Risk for Breast Cancer Mortality (95% CrI) Events … For women aged 39-49 y, the combined relative risk for breast cancer mortality for 8 trials was 0.85

264. Recommendation: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening
     December 10, 2019 - Assess risk . … significant. 1 , 37 Pooled analysis of all available trials also showed no effect on all-cause mortality (relative … small AAAs 12 , 16 , 37 , 38 in the Aneurysm Detection and Management (ADAM) Veterans Affairs trial (relative … risk, 0.18 [95% CI, 0.04-0.81]) and the UK Small Aneurysm Trial (UKSAT) (relative risk, 0.51 [95% CI … Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm

265. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/mk-eb9VtB_jx885wnjuzk3
     January 01, 2024 - For composite cardiovascular outcomes, relative risk estimates were very similar for men and women in … Although relative risk estimates across subgroups were simi- lar, absolute benefits were greater in subgroups … similar relative risk esti- mates, the absolute benefits of statin therapy will be greater in populations … Statins: is it really time to reassess benefits and risks? … Risks associated with statin therapy: a systematic overview of randomized clinical trials.

266. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Cardiovascular Events (April 11, 2016) Evidence Summary: Bleeding Risks … trials of low-dose aspirin (≤100 mg daily) showed a 17% reduction in nonfatal MI and coronary events (relative … is sufficiently high for the benefits to outweigh the risks associated with treatment; they suggest … In a consumer bulletin, it noted the risks for GI and intracranial bleeding and suggested that the benefits … Bleeding risks with aspirin use for primary prevention in adults: a systematic evidence review for the

267. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DCfAJZvNDzSYu7NqLJX2bv
     March 01, 2016 - was no difference in the likelihood of visual acuity worse than 20/60 after 3 to 5 years (37% vs 35%; relative … risks (RRs) and abso- lute risk differences. … difference in likelihood of visual acuity worse than 20/60 after 3- to 5-year follow-up (37% vs 35%; relative … risk. … of falls16 and, if an association is present, to identify methods for mitigating these risks.

268. Archived: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-screening-2008
     May 15, 2008 - Assessment Women at increased risk of developing gestational diabetes mellitus (GDM) include those … review, and identified and evaluated evidence that has become available since the prior review, on the risks … pregnancy-induced hypertension was 18% in the untreated women and 12% in the treated group (adjusted relative … risk, 0.70 [95% CI 0.51-0.95]). … With regard to potential fetal or newborn risks, the potential teratogenicity of certain newer treatments

269. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
     September 06, 2016 - of active TB at 5 years from 1.4% to 0.5% (relative risk [RR], 0.35 [95% CI, 0.24–0.52]) and an increase … years, 1.4% of the placebo group and 0.5% of the 24-week treatment group developed active TB, for a relative … The relative risk of possible hypersensitivity for rifapentine plus isoniazid vs isoniazid only was 8.04 … NNT, number needed to treat; PPD, purified protein derivative; RCT, randomized clinical trial; RR, relative … The relative risks for the other IUAT treatment groups for developing active TB compared with placebo

270. Draft Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/cervical-cancer-screening-adults-adolescents
     December 10, 2024 - Transgender men, nonbinary individuals, and others who were assigned female sex at birth have the same risks … Immunization with high-risk HPV vaccines is effective at reducing the risk of infection with HPV, cervical … screening can detect more CIN3+ lesions in one round of screening compared with cytologic testing (relative … 30 or 35 years) compared with older women (age >30 or 35 years). 1 The harms of treatment include risks … of unnecessary treatment (for false-positive results or lesions that would have regressed) include risks

271. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pACFPdCoN8fVoddBs-_CLE
     November 12, 2019 - Tamoxifen reduced invasive breast cancer more than raloxifene in the head-to-head trial (relative risk … Risks for breast, ovarian, and other types of BRCA- related cancer are greatly increased in patients … Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case … Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. … Familial breast cancer: classification, care and managing breast cancer and related risks in people with

272. Archived: Evidence Summary: Preeclampsia: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/preeclampsia-screening-april-2017
     April 25, 2017 - After risk prediction, women received counseling on potential risks of preeclampsia. … of pregnancy, rarity and unpredictability of severe preeclampsia, and interwoven maternal and fetal risks … Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. … A competing risks model in early screening for preeclampsia. … 907 (15.4) NR 0.04 Abbreviations: NR, not reported; RCT, randomized clinical trial; RR, relative

273. Archived: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
     September 09, 2014 - Clinical Risk Assessment for Preeclampsia * Risk Level Risk Factors Recommendation … risk for preeclampsia. … § Moderate-risk factors vary in their association with increased risk for preeclampsia. … Perinatal Outcomes The USPSTF found evidence of a 14% reduction in risk for preterm birth (pooled relative … The pooled relative risk for intracranial hemorrhage in neonates (6 studies; n = 22,158) was 0.84 (

274. W-9Tarc9Nkw6Pe4Sfddmkz (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/W-9TArc9nkw6Pe4sfddMKZ
     July 01, 2013 - We used the Mantel–Haenszel method for relative risks and the inverse variance method for pooling mean … , a correction fac- tor of 0.5 was added to each cell of the 2 � 2 table to obtain estimates of the relative … risk. … Third, this review assessed the risks and benefits of treating GDM but not those of screening for this … - termine the glucose thresholds and treatment targets at which GDM treatment benefits outweigh the risks

275. Archived: Evidence Summary: Screening for Breast Cancer: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-breast-cancer/breast-cancer-screening-january-2016
     January 11, 2016 - Data Synthesis: Fair-quality evidence from a meta-analysis of mammography trials indicated relative … risks (RRs) for breast cancer mortality of 0.92 for women aged 39 to 49 years (95% CI, 0.75 to 1.02) … We used a random-effects model to combine relative risks (RRs) as the effect measure of the meta-analyses … risk; USPSTF = U.S. … risk.

276. Archived: Final Evidence Review: Hepatitis B Virus Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review46/hepatitis-b-virus-infection-screening-2004
     February 15, 2004 - assessment tools to identify persons at high risk for HBV infection are valid? … at high risk for HBV infection. … truly high-risk individuals and those not disclosing their risk factors. … This, in turn, makes it difficult to discriminate between absolute risk and relative risk for HBV infection … Cost-effectiveness of preimmunization hepatitis B screening in high-risk adolescents.

277. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTJ_Zj3TAkhx45wWUDtNyt
     May 01, 2021 - The ACC/AHA risk estimator is, to date, the only US-based CVD risk prediction tool that has published … risk estimation tools. … (18 trials; n = 85 816; relative risk [RR], 0.92 [95% CI, 0.87 to 0.98]; absolute risk difference [ARD … for per- sons at borderline risk, and recommend consideration of risk en- hancers to refine risk assessments … Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from

278. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
     October 07, 2011 - The other found no statistically significant effect after 10 years (relative risk, 1.1 [CI, 0.80 to 1.5 … cancer–specific mortality compared with watchful waiting through 13 years of follow-up (relative risk … After 7 years' (complete) follow-up, screening was associated with increased prostate cancer incidence (relative … for harms, the likely effect on observational studies would be to underestimate risks. … ADT = androgen deprivation therapy; NR = not reported; RCT = randomized, controlled trial; RR = relative

279. Low-Dose Aspiring for the Prevention of Morbidity and Mortality from Preeclampsia: A Systematic Evidence Review fro the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6W538pkN7ft6TsRMKfPWMJ
     May 27, 2014 - pre- eclampsia (relative risk [RR], 0.76 [95% CI, 0.62 to 0.95]), 1% to 5% for intrauterine growth restriction … aspirin use (relative risk [RR], 0.81 [95% CI, 0.65 to 1.01]; I2 � 0%), but the result was not statis … Placental abruption‡ 1.12 (0.86–1.46) 3 12 366 50.1 0.135 1.17 (0.93–1.48) 8 22 988 36.4 0.138 RR � relative … Study in Pregnancy; MFMU � Maternal-Fetal Medicine Units; NR � not reported; PE � preeclampsia; RR � relative … Low-dose Aspirin Study in Pregnancy; MFMU � Maternal-Fetal Medicine Units; PE � preeclampsia; RR � relative

280. 4Nuuvs6Nmztdbgjbg3Elke (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/4NUuvS6nmzTdBgjBg3ELkE
     January 01, 2020 - 0.12 mmol/L (CI, 0.18 to 0.05 mmol/L) (2.08 mg/dL [CI, 3.29 to 0.88 mg/dL]), diabetes incidence by a relative … convert from mmol/L to mg/dL, divide by 0.0113. ‡ To convert from mmol/L to mg/dL, divide by 0.0555. § Relative … in a com- posite measure of all CVD events at 6.6 years of follow-up (relative risk, 0.71 [95% CI, 0.51 … disease; DBP � diastolic blood pressure; LDL � low-density lipoprotein; QOL � quality of life; RR � relative … , and metabolic risk factors.